which is best for weight loss semaglutide or tirzepatide vs Tirzepatide: GLP-1 Wins Loss? Tirzepatide vs Semaglutide: Key Differences

Tirzepatide has emerged as one of the most effective GLP-1 receptor agonists for weight management, with clinical trials showing average weight loss of 15-22% of baseline body weight over 68 weeks

Alcohol should also be avoided if you cannot keep fluids down, feel faint, or are having significant digestive symptoms

What Standard Panels Actually Look For, the starting point is regulatory status: retatrutide remains investigational as of May 2026 and is not FDA-approved

Questions to Ask About Compounding Specifically: "What accreditation does your compounding pharmacy hold?" "What testing do you perform on each batch to verify potency and purity?" "How do you handle adverse event reporting if something goes wrong?" "What is your protocol if I receive medication that appears different from previous doses?" If the answers to these questions aren't satisfactory or aren't provided clearly, that's useful information for your decision-making process

Registry identifiers include NCT05971940 (ACHIEVE-1) and NCT05869903 (ATTAIN-1)

Tirzepatide lowers blood sugar levels and promotes glycemic control more effectively than single GLP-1 receptor agonists such as semaglutide